Lido Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$923K Sell
4,086
-1,206
-23% -$256K ﹤0.01% 1132
2026
Q2
$1.14M Buy
5,292
+860
+19% +$165K ﹤0.01% 1033
2026
Q1
$813K Sell
4,432
-1,559
-26% -$287K ﹤0.01% 1063
2025
Q4
$865K Sell
5,991
-308
-5% -$50.3K ﹤0.01% 1067
2025
Q3
$882K Buy
6,299
+1,151
+22% +$156K ﹤0.01% 1001
2025
Q2
$647K Sell
5,148
-37,897
-88% -$4.72M ﹤0.01% 1014
2025
Q1
$5.89M Buy
43,045
+1,447
+3% +$207K 0.03% 315
2024
Q4
$6.36M Buy
41,598
+39,910
+2,364% +$6.73M 0.03% 284
2024
Q3
$327K Sell
1,688
-697
-29% -$146K ﹤0.01% 1120
2024
Q2
$553K Sell
2,385
-189
-7% -$41.1K ﹤0.01% 900
2024
Q1
$555K Sell
2,574
-241
-9% -$56.4K ﹤0.01% 871
2023
Q4
$728K Buy
2,815
+1,843
+190% +$453K ﹤0.01% 725
2023
Q3
$250K Buy
972
+233
+32% +$62.3K ﹤0.01% 997
2023
Q2
$211K Buy
+739
New +$220K ﹤0.01% 1087
2021
Q3
– Sell
-705
Closed -$244K – 964
2021
Q2
$244K Buy
+705
New +$214K ﹤0.01% 798

Other funds holding BIIB

Lido Advisors's BIIB Position: Q3 2026 in Review

Lido Advisors reduced its Biogen (BIIB) stake by 23% in Q3 2026, selling an estimated $256K and leaving 4,086 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Lido Advisors first reported a position in BIIB in Q2 2021 and has held it in 15 quarters since. The position peaked at $6.36M in Q4 2024. 901 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Lido Advisors held 4,086 shares of Biogen worth $923K as of Q3 2026.
  • Lido Advisors sold 1,206 Biogen shares in Q3 2026, an estimated $256K.
  • Biogen made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #1132 holding.
  • Lido Advisors first reported a position in Biogen in Q2 2021 and has held it in 15 quarters since.
  • Lido Advisors's Biogen position peaked at $6.36M in Q4 2024.
  • 901 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.